European Union Drugs Agency. (2026) Other drugs – the current situation in Europe (European drug report 2026). Lisbon: EUDA.
External website: https://www.euda.europa.eu/publications/european-d...
Alongside the more well-known substances available on illicit drug markets, a number of other substances with hallucinogenic, anaesthetic, dissociative or depressant properties are used in Europe: these include LSD (lysergic acid diethylamide), hallucinogenic mushrooms, ketamine and GHB (gamma-hydroxybutyrate). On this page, you can find the latest analysis regarding these substances in Europe, including seizures, prevalence and patterns of use, treatment entry, harms and more.
This page is part of the European Drug Report 2026, the EUDA’s annual overview of the drug situation in Europe.
A Substance use and dependence > Substance related societal (social) problems / harms
B Substances > Hallucinogens / Psychedelics > LSD (Lysergic acid diethylamide)
B Substances > Hallucinogens / Psychedelics > Mushrooms (psilocybin / Amanita muscaria /Psilocybe)
B Substances > New (novel) psychoactive substances > Aminoindanes / Arylalkylamines / Arylcyclohexylamines > Ketamine
B Substances > New (novel) psychoactive substances > Other novel substances > GHB / GBL (Gamma hydroxybutyric / Gamma butyrolactone)
E Concepts in biomedical areas > Pharmacology and toxicology
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
MM-MO Crime and law > Substance related offence > Drug offence > Illegal production of drugs
MM-MO Crime and law > Substance related offence > Drug offence > Illegal transportation of drugs (smuggling / trafficking)
MM-MO Crime and law > Substance related offence > Drug offence > Illegal distribution of drugs (drug market / dealing)
MM-MO Crime and law > Substance related offence > Drug offence > Illegal drug possession (seizures)
VA Geographic area > Europe
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page